Personalized T-cell therapy eliminates detectable metastatic kidney tumor in adolescent after multiple relapses
AI Summary
An adolescent patient with advanced metastatic kidney cancer achieved complete tumor remission after receiving a novel personalized T-cell therapy. The treatment was conducted by leading cancer centers and demonstrates innovative progress in personalized immunotherapy for resistant tumors.
Researchers and physicians at the Hopp Children's Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment outcome in an adolescent with an advanced, treatment-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely reversing the disease despite multiple metastases.
Health personalized therapy T-cell therapy kidney cancer metastatic tumor immunotherapy oncology adolescent patient